OSE Immunotherapeutics Stock Börse Stuttgart
Stocks
6OP
FR0012127173
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Börse Stuttgart
12:47:23 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 2.570 EUR | -0.62% |
|
-4.43% | -48.74% |
| 09-20 | OSE Immunotherapeutics SA(ENXTPA:OSE) dropped from S&P Global BMI Index | CI |
| 09-09 | OSE Immunotherapeutics: first patient treated in a Phase 2 study |  |
| Market Cap | 60.73M 69.52M 57.04M 52.09M 97.77M 6.65B 97.7M 684M 264M 3.39B 261M 255M 10.95B | P/E 2026 * |
-1.98x | P/E 2027 * | -2.27x |
|---|---|---|---|---|---|
| Enterprise Value | 102M 116M 95.36M 87.08M 163M 11.11B 163M 1.14B 441M 5.67B 436M 427M 18.3B | EV / Sales 2026 * |
20.7x | EV / Sales 2027 * | 11.8x |
| Free-Float |
78.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| OSE | Real-time | |
Börse Stuttgart
| 6OP | Delayed | |
|
CBOE
| OSEp | Real-time | |
|
Tradegate
| 6OP | Real-time | |
|
Deutsche Boerse AG
| 6OP | Delayed | |
|
CBOE
| 0RAD | Real-time | |
|
Boerse Muenchen
| 6OP | Real-time |
Last Transcript: OSE Immunotherapeutics
| 1 week | -3.24% | ||
| Current month | -19.59% | ||
| 1 month | -22.45% | ||
| 3 months | -24.46% | ||
| 6 months | -24.46% | ||
| Current year | -49.06% |
| 1 week | 2.54 |  | 2.72 |
| 1 month | 2.54 | | 3.31 |
| 3 years | 2.54 | | 10.74 |
| 5 years | 2.54 | | 11.68 |
| 10 years | 2.54 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Bozec
CEO | Chief Executive Officer | - | 2025-10-01 |
Thomas Gidoin
DFI | Director of Finance/CFO | 43 | 2025-08-19 |
Silvia Comis
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-19 |
| Director | Title | Age | Since |
|---|---|---|---|
Maryvonne Hiance
BRD | Director/Board Member | 77 | 2016-05-30 |
Brigitte Dreno
BRD | Director/Board Member | 73 | 2017-06-13 |
| Director/Board Member | - | 2023-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | -4.43% | -56.29% | -41.92% | 69.87M | |
| +2.55% | +5.35% | +3.61% | +32.02% | 46.68B | |
| +0.08% | +1.66% | +44.26% | +35.60% | 44.42B | |
| +0.05% | -5.97% | +342.95% | +532.74% | 41.32B | |
| +0.66% | +4.03% | +10.07% | +96.02% | 41.58B | |
| -1.60% | -0.17% | +9.73% | +43.63% | 30.14B | |
| +0.96% | +5.84% | +26.39% | +161.70% | 17.42B | |
| -0.01% | -10.32% | - | - | 15.6B | |
| +1.15% | +9.42% | +26.21% | +42.84% | 15.54B | |
| -1.08% | +24.08% | -12.52% | - | 14.08B | |
| Average | +0.43% | +3.39% | +43.82% | +112.83% | 29.64B | |
| Weighted average by Cap. | +0.52% | +1.94% | +70.46% | +142.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.9M 5.61M 4.6M 4.2M 7.89M 536M 7.88M 55.16M 21.28M 274M 21.05M 20.6M 883M | 10.53M 12.05M 9.89M 9.03M 16.95M 1.15B 16.94M 119M 45.74M 588M 45.24M 44.27M 1.9B |
| Net income | -30.59M -35.01M -28.73M -26.24M -49.24M -3.35B -49.21M -344M -133M -1.71B -131M -129M -5.51B | -21.47M -24.57M -20.16M -18.41M -34.56M -2.35B -34.54M -242M -93.25M -1.2B -92.24M -90.26M -3.87B |
| Net Debt | 40.79M 46.69M 38.31M 34.99M 65.67M 4.47B 65.63M 459M 177M 2.28B 175M 172M 7.35B | 63.08M 72.21M 59.26M 54.11M 102M 6.91B 101M 710M 274M 3.52B 271M 265M 11.37B |
| Date | Price | Change |
|---|---|---|
| 26-09-22 | €2.570 | -0.62% |
| 26-09-21 | €2.586 | -0.23% |
| 26-09-18 | €2.592 | -1.67% |
| 26-09-17 | €2.636 | +2.09% |
| 26-09-16 | €2.582 | -2.79% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- OSE Stock
- 6OP Stock
Select your edition
All financial news and data tailored to specific country editions
